cloudyn.png
Friday January 21st, 2022 8:47PM

Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021

By The Associated Press

ATLANTA--(BUSINESS WIRE)--Nov 4, 2021--

(Nasdaq: ), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic pain and fatigue related diseases, announced today that its third quarter 2021 financial results will be reported on Thursday, November 11, 2021 before the open of the financial markets. Management will also host a webcast and conference call on November 11, 2021 at 8:30 a.m. ET to discuss the results and provide a corporate update.

The live and archived webcast of the call may be accessed on the Virios Therapeutics website under the Investors section: . The live call can also be accessed by dialing 888-506-0062 (domestic) or 973-528-0011 (international) using the access code: 345081.

Virios Therapeutics (Nasdaq: ) is a development-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as fibromyalgia (“FM”). Immune responses related to the activation of tissue resident Herpes Simplex Virus-1 (“HSV-1”) have been postulated as a potential root cause triggering and/or sustaining chronic illnesses such as FM, irritable bowel disease (“IBS”), chronic fatigue syndrome and other functional somatic syndromes, all of which are characterized by waxing and waning symptoms with no obvious etiology. Our lead development candidate (“IMC-1”) is a novel, proprietary, fixed dose combination of famciclovir and celecoxib designed to synergistically suppress HSV-1 replication.

Evidence of IMC-1’s efficacy on a broad spectrum of FM outcome measures was previously demonstrated in a Phase 2a clinical trial. These trial results are suggestive that IMC-1 may represent a new and novel treatment for fibromyalgia. IMC-1 has been granted fast track designation by the FDA and is currently being tested in a multi-center, randomized, double-blind, placebo-controlled 460 patient Phase 2b trial (“FORTRESS”) designed to set the stage for registrational studies. The Company is led by an executive team highly experienced in the successful development and commercialization of novel therapies. For more information, please visit .

Statements in this press release contain “forward-looking statements”, within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” "will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Virios Therapeutics’ current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the completion and timing of the FORTRESS trial. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Virios Therapeutics, Inc. (VIRI) undertakes no duty to update such information except as required under applicable law.

View source version on businesswire.com:

CONTACT: Dave Gentry

1-800-733-2447

+1-407-491-4498

[email protected]

or

[email protected]

 

KEYWORD: GEORGIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH WOMEN CONSUMER

SOURCE: Virios Therapeutics, Inc. (VIRI)

Copyright Business Wire 2021.

PUB: 11/04/2021 07:05 AM/DISC: 11/04/2021 07:06 AM

http://www.businesswire.com/news/home/20211104005091/en

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Online - Georgia News, AP Business Wire - Georgia
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
UK authorizes Merck antiviral pill, 1st shown to treat COVID
Britain has granted a conditional authorization to Merck’s coronavirus antiviral
7:13AM ( 14 minutes ago )
Japan labor leader vows to fight for stable, better work
The head of Japan's largest labor federation says she is determined to listen to the voices of all workers in fighting for better wages and conditions
7:11AM ( 15 minutes ago )
The AP Interview: Justice Dept. conducting cyber crackdown
U.S. authorities are expecting arrests and criminal charges related to ransomware in the coming weeks
7:07AM ( 19 minutes ago )
Associated Press (AP)
Global shares up after Fed says economic aid will wind down
Global shares are rising, boosted by the U.S. Federal Reserve's announcement that it will begin winding down the extraordinary aid for the economy it has been providing since early in the pandemic
4:52AM ( 2 hours ago )
UK interest rates set to rise amid high inflation
The Bank of England is widely expected to raise interest rates in order to combat rising inflation, a move that is likely to make mortgages and loans more costly
4:46AM ( 2 hours ago )
Israel spared fifth snap election as lawmakers pass budget
Israel’s parliament has passed a national budget for the first time in three years, avoiding a November deadline that would have brought down the new government and triggered another election
4:44AM ( 2 hours ago )
AP Business
Roll up your sleeves: Kids' turn arrives for COVID-19 shots
Schoolchildren take the spotlight this week as the U.S. enters a new phase in COVID-19 vaccination aimed at curbing deaths, hospitalizations and more than a year of disrupted education
6:08PM ( 13 hours ago )
Thai companies accused of fraud in sales of medical gloves
Police in Thailand have announced the arrest of the head of a company suspected of cheating overseas buyers of millions of dollars paid for undelivered medical rubber gloves during the coronavirus pandemic
10:03AM ( 21 hours ago )
Stocks open lower on Wall Street, edging below record highs
Stocks are opening slightly lower on Wall Street as investors look over another big batch of earnings reports from U.S. companies, which contained some disappointments
9:45AM ( 21 hours ago )
AP Business - Corporate News
Surging Miami back in ACC Coastal Division race
Miami is surging
4:17AM ( 3 hours ago )
No. 12 Auburn playing to stay in SEC West race at No. 13 A&M
No. 12 Auburn is looking to stay in contention for the Southeastern Conference Western Division against No. 13 Texas A&M, the team that kept the Tigers' hopes alive with the Aggies' win over Alabama
2:02AM ( 5 hours ago )
Durant scores 32, Nets hit 22 3s in 117-108 win over Hawks
Kevin Durant scored 32 points and led the spurt that broke open the game late in the third quarter, and the Brooklyn Nets beat the Atlanta Hawks 117-108 for their third straight victory
11:04PM ( 8 hours ago )
AP Online - Georgia News
AP Business Wire - Georgia
UK authorizes Merck antiviral pill, 1st shown to treat COVID
Britain has granted a conditional authorization to Merck’s coronavirus antiviral
7:13AM ( 16 minutes ago )
Japan labor leader vows to fight for stable, better work
The head of Japan's largest labor federation says she is determined to listen to the voices of all workers in fighting for better wages and conditions
7:11AM ( 18 minutes ago )
The AP Interview: Justice Dept. conducting cyber crackdown
U.S. authorities are expecting arrests and criminal charges related to ransomware in the coming weeks
7:07AM ( 22 minutes ago )
Vietnam seeks information from Iran about seized oil tanker
Vietnam is seeking more information about a Vietnamese oil tanker that was seized at gunpoint last month by Iranian soldiers in the Gulf of Oman, while vowing to ensure the safety and humane treatment of the ship's crew members
6:51AM ( 39 minutes ago )
Tennis, sex and politics combine in Chinese #MeToo scandal
Chinese authorities have squelched virtually all online discussion of sexual assault accusations apparently made by a Chinese professional tennis star against a former top government official, showing how sensitive the ruling Communist Party is to such charges
6:49AM ( 40 minutes ago )